| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | telomerase RNA binding | 4.08e-04 | 25 | 24 | 2 | GO:0070034 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 9.98e-04 | 39 | 24 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 1.05e-03 | 40 | 24 | 2 | GO:0042162 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | 4.19e-06 | 1194 | 24 | 9 | GO:0048609 | |
| GeneOntologyBiologicalProcess | sexual reproduction | 9.06e-06 | 1312 | 24 | 9 | GO:0019953 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 4.53e-05 | 60 | 24 | 3 | GO:0032210 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 6.90e-05 | 69 | 24 | 3 | GO:1904356 | |
| GeneOntologyBiologicalProcess | gamete generation | 9.20e-05 | 982 | 24 | 7 | GO:0007276 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 9.57e-05 | 77 | 24 | 3 | GO:0007004 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.07e-04 | 217 | 24 | 4 | GO:0006403 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.20e-04 | 83 | 24 | 3 | GO:0006278 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 1.52e-04 | 90 | 24 | 3 | GO:0010833 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.62e-04 | 92 | 24 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 2.90e-04 | 112 | 24 | 3 | GO:0032204 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 4.70e-04 | 132 | 24 | 3 | GO:0000956 | |
| GeneOntologyBiologicalProcess | artery development | 4.80e-04 | 133 | 24 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | lipoprotein transport | 4.81e-04 | 28 | 24 | 2 | GO:0042953 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 5.17e-04 | 29 | 24 | 2 | GO:0044872 | |
| GeneOntologyBiologicalProcess | synaptonemal complex assembly | 5.17e-04 | 29 | 24 | 2 | GO:0007130 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 5.35e-04 | 138 | 24 | 3 | GO:2000278 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | 6.30e-04 | 1342 | 24 | 7 | GO:0033043 | |
| GeneOntologyBiologicalProcess | synaptonemal complex organization | 6.30e-04 | 32 | 24 | 2 | GO:0070193 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomerase | 7.98e-04 | 36 | 24 | 2 | GO:0032212 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomere lengthening | 9.37e-04 | 39 | 24 | 2 | GO:1904358 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 9.47e-04 | 168 | 24 | 3 | GO:0000723 | |
| GeneOntologyBiologicalProcess | chromosome organization | 1.01e-03 | 686 | 24 | 5 | GO:0051276 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 1.09e-03 | 42 | 24 | 2 | GO:0032205 | |
| HumanPheno | Spermatocyte maturation arrest | 5.99e-05 | 5 | 13 | 2 | HP:0031039 | |
| HumanPheno | Obstructive azoospermia | 8.11e-05 | 35 | 13 | 3 | HP:0011962 | |
| MousePheno | abnormal manchette morphology | 3.98e-05 | 45 | 21 | 3 | MP:0009376 | |
| MousePheno | abnormal manchette assembly | 9.60e-05 | 10 | 21 | 2 | MP:0031374 | |
| MousePheno | cardiac hypertrophy | 1.86e-04 | 196 | 21 | 4 | MP:0001625 | |
| MousePheno | decreased male germ cell number | 2.70e-04 | 640 | 21 | 6 | MP:0004901 | |
| MousePheno | decreased germ cell number | 3.96e-04 | 687 | 21 | 6 | MP:0002209 | |
| MousePheno | arrest of spermatogenesis | 3.97e-04 | 239 | 21 | 4 | MP:0001155 | |
| Domain | Quinoprot_gluc/sorb_DH | 1.04e-04 | 12 | 24 | 2 | IPR011041 | |
| Domain | EGF_CA | 5.42e-03 | 86 | 24 | 2 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 6.84e-03 | 97 | 24 | 2 | IPR018097 | |
| Domain | EGF_CA | 7.12e-03 | 99 | 24 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.25e-03 | 100 | 24 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.12e-03 | 106 | 24 | 2 | IPR000152 | |
| Domain | EGF_CA | 1.06e-02 | 122 | 24 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.10e-02 | 124 | 24 | 2 | IPR001881 | |
| Domain | Growth_fac_rcpt_ | 1.70e-02 | 156 | 24 | 2 | IPR009030 | |
| Pathway | WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION | 4.83e-04 | 31 | 15 | 2 | M39514 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 8.46e-04 | 41 | 15 | 2 | M159 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 9.73e-04 | 190 | 15 | 3 | MM15687 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.02e-03 | 45 | 15 | 2 | MM15344 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.16e-03 | 48 | 15 | 2 | M27642 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 16362633 | ||
| Pubmed | Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice. | 2.97e-06 | 4 | 25 | 2 | 9788969 | |
| Pubmed | Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. | 1.04e-05 | 7 | 25 | 2 | 23676495 | |
| Pubmed | Integrative predictive model of coronary artery calcification in atherosclerosis. | 2.08e-05 | 229 | 25 | 4 | 19948975 | |
| Pubmed | 5.00e-05 | 963 | 25 | 6 | 28671696 | ||
| Pubmed | 5.17e-05 | 1442 | 25 | 7 | 35575683 | ||
| Pubmed | 1.26e-04 | 136 | 25 | 3 | 25429064 | ||
| Pubmed | 1.99e-04 | 29 | 25 | 2 | 20167577 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 2.17e-04 | 420 | 25 | 4 | 28065597 | |
| Pubmed | Genetic associations of brain structural networks in schizophrenia: a preliminary study. | 2.28e-04 | 31 | 25 | 2 | 20691427 | |
| Pubmed | 2.41e-04 | 432 | 25 | 4 | 7671812 | ||
| Pubmed | 3.76e-04 | 197 | 25 | 3 | 32434143 | ||
| Pubmed | 4.61e-04 | 44 | 25 | 2 | 31273033 | ||
| Pubmed | 4.63e-04 | 513 | 25 | 4 | 25798074 | ||
| Pubmed | 5.26e-04 | 47 | 25 | 2 | 11208732 | ||
| Pubmed | 5.39e-04 | 223 | 25 | 3 | 20020773 | ||
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 5.60e-04 | 226 | 25 | 3 | 25900982 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 6.05e-04 | 232 | 25 | 3 | 25515538 | |
| Pubmed | 6.43e-04 | 52 | 25 | 2 | 26265008 | ||
| Pubmed | 6.75e-04 | 241 | 25 | 3 | 23125841 | ||
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 6.92e-04 | 243 | 25 | 3 | 36964488 | |
| Pubmed | 7.00e-04 | 244 | 25 | 3 | 29884807 | ||
| Interaction | CPE interactions | 3.54e-05 | 54 | 24 | 3 | int:CPE | |
| Interaction | UPF1 interactions | 4.83e-05 | 581 | 24 | 6 | int:UPF1 | |
| Interaction | SCAI interactions | 4.86e-05 | 60 | 24 | 3 | int:SCAI | |
| Interaction | ADGRV1 interactions | 6.46e-05 | 66 | 24 | 3 | int:ADGRV1 | |
| Interaction | CALCR interactions | 1.05e-04 | 13 | 24 | 2 | int:CALCR | |
| Interaction | CALR interactions | 1.10e-04 | 414 | 24 | 5 | int:CALR | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.64e-05 | 239 | 25 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | migraine disorder, pulse pressure measurement | 2.21e-04 | 26 | 25 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | Colorectal Carcinoma | 2.69e-04 | 702 | 25 | 5 | C0009402 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.73e-04 | 150 | 25 | 3 | EFO_0004611, EFO_0020947 | |
| Disease | dyslexia | 3.42e-04 | 162 | 25 | 3 | EFO_0005424 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 6.32e-04 | 200 | 25 | 3 | EFO_0004611, EFO_0020945 | |
| Disease | apolipoprotein A 1 measurement | 6.38e-04 | 848 | 25 | 5 | EFO_0004614 | |
| Disease | Celiac Disease | 7.28e-04 | 47 | 25 | 2 | C0007570 | |
| Disease | cholesteryl ester 20:3 measurement | 7.91e-04 | 49 | 25 | 2 | EFO_0010347 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 8.55e-04 | 222 | 25 | 3 | EFO_0008317, EFO_0020943 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 8.57e-04 | 51 | 25 | 2 | EFO_0022302 | |
| Disease | triglycerides in medium VLDL measurement | 9.96e-04 | 55 | 25 | 2 | EFO_0022155 | |
| Disease | cholesterol to total lipids in large HDL percentage | 9.96e-04 | 55 | 25 | 2 | EFO_0022234 | |
| Disease | triglycerides in very large VLDL measurement | 1.03e-03 | 56 | 25 | 2 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 1.03e-03 | 56 | 25 | 2 | EFO_0022333 | |
| Disease | triglycerides in large VLDL measurement | 1.03e-03 | 56 | 25 | 2 | EFO_0022178 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 1.03e-03 | 56 | 25 | 2 | EFO_0022251 | |
| Disease | triglycerides in VLDL measurement | 1.14e-03 | 59 | 25 | 2 | EFO_0022326 | |
| Disease | cholesterol in medium HDL measurement | 1.14e-03 | 59 | 25 | 2 | EFO_0021903 | |
| Disease | phospholipids in VLDL measurement | 1.14e-03 | 59 | 25 | 2 | EFO_0022301 | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.18e-03 | 60 | 25 | 2 | EFO_0022330 | |
| Disease | total lipids in VLDL measurement | 1.18e-03 | 60 | 25 | 2 | EFO_0022314 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 1.18e-03 | 60 | 25 | 2 | EFO_0022237 | |
| Disease | triglycerides in small VLDL measurement | 1.22e-03 | 61 | 25 | 2 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 1.22e-03 | 61 | 25 | 2 | EFO_0022274 | |
| Disease | free cholesterol in HDL measurement | 1.22e-03 | 61 | 25 | 2 | EFO_0022264 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.26e-03 | 62 | 25 | 2 | EFO_0022339 | |
| Disease | triglycerides in small HDL measurement | 1.26e-03 | 62 | 25 | 2 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 1.26e-03 | 62 | 25 | 2 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 1.26e-03 | 62 | 25 | 2 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 1.26e-03 | 62 | 25 | 2 | EFO_0022299 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.30e-03 | 63 | 25 | 2 | EFO_0001645, EFO_0004792 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RYNFKIQSNNFSYQV | 1301 | Q5DID0 | |
| SRQAQASYYKFQNSD | 491 | Q86US8 | |
| KQQNQYQASYNQSFS | 536 | Q14444 | |
| NSLQSYQLSPNNYFS | 166 | Q9Y5H2 | |
| NFQYENFFNYVTNID | 616 | Q9NVR2 | |
| YTLQNHYYRNNSFTA | 546 | O95453 | |
| NAAYEQSHFFNKNYT | 711 | Q5T3J3 | |
| FMANNQSFYSNREQY | 651 | Q9H3C7 | |
| NYLYATNSDNANAQQ | 421 | Q07954 | |
| YNWSYTQFSQFNKDD | 136 | Q969U6 | |
| NFFIQSYNNASNDTY | 46 | Q9H114 | |
| TQVAYFLANRQNNYD | 101 | Q9H094 | |
| QFNNNEYSQDLDAYN | 1986 | P04114 | |
| QNFYSDYNTTYSIQA | 371 | P51168 | |
| DSNANQKEFNSLYFY | 1371 | Q5VXU9 | |
| VDSYNQRNANISYAF | 686 | Q68BL8 | |
| FFKSELNQLYQSQYN | 1911 | Q6Q759 | |
| NTFAQYQYQHQNRSE | 96 | A4UGR9 | |
| YDQAQLAVAYSQAFQ | 336 | Q8TB22 | |
| AVYSAASSYYQQQQQ | 271 | Q96KR1 | |
| SNLAQFDSDFYQSNF | 26 | Q8N8F6 | |
| YSKESNYFYSSTQNN | 746 | Q9BXT5 | |
| SYNDFGNYNNQSSNF | 311 | P09651 | |
| AFASYNKFNNNCYQD | 346 | P31645 | |
| NGQNNTFSGSSYSNY | 476 | Q9ULJ6 |